Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 6/20 | 0.59 |
| ▸ | LDHA | P00338 | 1/20 | 0.51 |
| ▸ | LDHB | P07195 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.49 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | IDH2 | P48735 | 1/20 | 0.48 |
| ▸ | RAF1 | P04049 | 1/20 | 0.48 |
| ▸ | BRAF | P15056 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18023933 | 0.87 | CSF1R (0.58) | CSF1RLDHALDHBKMT2ASMN1; SMN2 | |
| SCHEMBL18023930 | 0.87 | CSF1R (0.64) | CSF1RLDHALDHBMEN1KMT2A | |
| SCHEMBL18023932 | 0.85 | CSF1R (0.60) | CSF1RLDHALDHBMEN1KMT2A | |
| SCHEMBL13339854 | 0.82 | CSF1R (0.77) | CSF1RLDHALDHBHTTSMN1; SMN2 | |
| SCHEMBL13340361 | 0.81 | CSF1R (0.73) | CSF1RLDHALDHBMEN1KMT2A | |
| SCHEMBL19447218 | 0.81 | LDHA (0.56) | CSF1RLDHALDHBKDRBRAF | |
| SCHEMBL13340426 | 0.80 | CSF1R (0.72) | CSF1RLDHALDHBKDR | |
| SCHEMBL17954640 | 0.79 | CSF1R (0.73) | CSF1RLDHALDHBKDR | |
| SCHEMBL20100909 | 0.79 | CSF1R (0.72) | CSF1RLDHALDHBHTTKDR | |
| SCHEMBL13340396 | 0.79 | CSF1R (0.70) | CSF1RLDHALDHBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3054937-B1 | SPRAY DRY FORMULATIONS | PULMOKINE INC (US) | 2023-07-26 | — | — | EP | disclosed |
| US-20160235742-A1 | SPRAY DRY FORMULATIONS | GILEAD SCIENCES, INC. | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160235742-A1 | SPRAY DRY FORMULATIONS | FLT1, KDR, ERBB2 | CSF1R 169/4885LDHA 4402/4885LDHB 4104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.